SPL
AKTS icon

Superior Planning, LLC’s Aktis Oncology AKTS Stock Holding History

Superior Planning, LLC’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.91K Buy
+98
New +$2.39K ﹤0.01% 1578

Other funds holding AKTS

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Superior Planning, LLC's AKTS Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Aktis Oncology (AKTS) in Q3 2026: 98 shares worth $1.91K. The stake represents ﹤0.01% of the portfolio and ranks #1578 among its holdings.

51 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • Superior Planning, LLC held 98 shares of Aktis Oncology worth $1.91K as of Q3 2026.
  • Aktis Oncology was a new Superior Planning, LLC position in Q3 2026.
  • Aktis Oncology made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1578 holding.
  • 51 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.